secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telesis Bio Inc. (—)
CIK:        0001850079
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0000950170-23-062201
Event type: debt
Sentiment:  negative
Materiality: 0.75
Item codes: 2.04
LLM model:  deepseek-v4-flash:cloud@v2

Telesis Bio in default on term loan; lender demands $15M repayment and warrant for 275K shares
--------------------------------------------------------------------------------

- As of Sep 30, 2023, company defaulted on financial revenue covenants under 2022 Term Loan Agreement with MidCap.
- On Nov 3, 2023, lender demanded $15M repayment in Nov 2023 and a warrant for 275,000 shares at 10-day VWAP.
- Total repayment obligation including exit fee and penalty is approximately $21.7M plus $0.3M prepayment penalty for revolving loan.
- In exchange, lender would waive defaults, reset revenue covenants, reduce prepayment penalty to 1%, and reduce exit fee by $350K.
- Future extensions of credit under 2022 Revolving Loan Agreement would be frozen.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850079/000095017023062201/0000950170-23-062201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850079/000095017023062201/tbio-20231103.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-062201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer